Do we need to see to believe?-radiomics for lung nodule classification and lung cancer risk stratification.

ABSTRACT: Despite multiple recent advances, the diagnosis and management of lung cancer remain challenging and it continues to be the deadliest malignancy. In 2011, the National Lung Screening Trial (NLST) reported 20% reduction in lung cancer related mortality using annual low dose chest computed tomography (CT). These results led to the approval and nationwide establishment of lung cancer CT-based lung cancer screening programs. These findings have been further validated by the recently published Nederlands-Leuvens Longkanker Screenings Onderzoek (NELSON) and Multicentric Italian Lung Detection (MILD) trials, the latter showing benefit of screening even beyond the 5 years. However, the implementation of lung cancer screening has been impeded by several challenges, including the differentiation bet

SUBMITTER: Khawaja A 

PROVIDER: S-EPMC7330769 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature